Longevity Health Holdings, Inc.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
XAGE$0.23-13.1%Stored close · as of Jul 8, 2026
Contents
Item 1. Unaudited Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (unaudited) | ||
| ASSETS | ||
| Current assets: | ||
| Cash | $770,047 | $157,139 |
| Accounts receivable | 94,753 | 4,096 |
| Inventory | 1,379,640 | 108,705 |
| Prepaid expenses | 246,899 | 297,462 |
| Deferred offering costs | — | 86,314 |
| Income taxes receivable | 301,838 | 301,838 |
| Total current assets | 2,793,177 | 955,554 |
| Operating lease right of use asset | 386,844 | 384,879 |
| Property and equipment, net of accumulated depreciation of $724,470 and $701,655, respectively | 138,709 | 113,906 |
| Intangible assets, net of accumulated amortization of $52,242 and $51,105, respectively | 18,504 | 19,641 |
| Total assets | $3,337,234 | $1,473,980 |
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | ||
| Current liabilities: | ||
| Accounts payable | $4,598,791 | $4,058,091 |
| Accrued interest | 1,175,845 | 1,175,845 |
| Accrued expenses and other liabilities | 476,911 | 313,713 |
| Loans payable | 119,409 | 241,158 |
| Consideration payable | 67,742 | — |
| Earnout liabilities | 46,642 | — |
| Operating lease liability | 113,573 | 87,898 |
| Total current liabilities | 6,598,913 | 5,876,705 |
| Long-term liabilities: | ||
| Earnout payable, net of current portion | 254,991 | — |
| Operating lease liability, net of current portion | 288,615 | 309,937 |
| Total liabilities | 7,142,519 | 6,186,642 |
| Commitments and contingencies (see Note 9) | ||
| Stockholders’ deficit: | ||
| Series A convertible voting preferred stock, $0.0001 par value; -0- and 4,243 shares authorized, -0- shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | — | — |
| Common stock, $0.0001 par value, 250,000,000 shares authorized, and 1,003,995 and 696,847 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively | 100 | 70 |
| Additional paid-in capital | 66,572,144 | 64,158,930 |
| Accumulated deficit | (70,377,529) | (68,871,662) |
| Total stockholders’ deficit | (3,805,285) | (4,712,662) |
| Total liabilities and stockholders’ deficit | $3,337,234 | $1,473,980 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.